Chiropractors in Marrero, LA Accepting Medicare

7 Chiropractors found. Showing 1 - 7

Dr. Paul D Bryant, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 6555 4th St, Marrero, LA 70072 Phone: 504-341-3293

Dr. Minh Trinh, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2201 Barataria Blvd, Suite F, Marrero, LA 70072 Phone: 504-218-4891    Fax: 504-218-4892

Dr. Quoc Thai Nguyen, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2201 Barataria Blvd, Suite F, Marrero, LA 70072 Phone: 504-218-4891

Ron Mosel, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1998 Barataria Blvd, Marrero, LA 70072 Phone: 504-340-1234    Fax: 504-340-7926

Injury Rehab Clinic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4700 Wichers Dr, Suite 307, Marrero, LA 70072 Phone: 504-340-8700    Fax: 504-340-8701

Twdd, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1998 Barataria Blvd, Marrero, LA 70072 Phone: 504-340-1234    Fax: 504-340-6623

Lift Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2201 Barataria Blvd, Suite F, Marrero, LA 70072 Phone: 504-218-4891    Fax: 504-218-4892

News Archive

HRA Pharma announces FDA Advisory Committee approval for ulipristal acetate as emergency contraceptive

HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.

RBC Life Sciences company-wide net sales rises to $7.8 million in second quarter

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, today reported company-wide net sales of $7.8 million for the second quarter ended June 30, 2010, compared to net sales of $6.8 million for the same period during 2009, an increase of 16%. Net sales for the six months ended June 30, 2010 also increased 16% to $14.8 million compared to net sales of $12.8 million during the same period in 2009.

Rhythm presents RM-131 Phase 1 clinical trial results for diabetic gastroparesis at ACG 2012

Rhythm announced today the results of two Phase 1 clinical trials of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis, which demonstrated that RM-131 greatly accelerates gastric emptying in healthy subjects with good tolerability.

Actuaries' study projects health law will boost claims costs 32 percent

Although some states would see claims costs decline, the study by the Society of Actuaries forecasts that a majority will experience double-digit increases in the individual health insurance market. Officials in some states disputed the analysis, saying it was based on flawed data.

Read more Medical News

› Verified 9 days ago